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ifferentiation of skeletal myoblasts into multinucle-
ated myotubes is a multistep process orchestrated
by several families of transcription factors, including
myogenic bHLH and NFAT proteins. The activities of these
factors and formation of myotubes are regulated by signal
transduction pathways, but few extracellular factors that
might initiate such signals have been identiﬁed. One ex-
ception is a cell surface complex containing promyogenic
Ig superfamily members (CDO and BOC) and cadherins.
Netrins and their receptors are established regulators of
axon guidance, but little is known of their function outside
D
 
the nervous system. We report here that myoblasts express
the secreted factor netrin-3 and its receptor, neogenin.
These proteins stimulate myotube formation and enhance
myogenic bHLH- and NFAT-dependent transcription. Fur-
thermore, neogenin binds to CDO in a cis fashion, and
myoblasts lacking CDO are defective in responding to
recombinant netrin. It is proposed that netrin-3 and neogenin
may promote myogenic differentiation by an autocrine
mechanism as components of a higher order complex of
several promyogenic cell surface proteins.
 
Introduction
 
During skeletal muscle development mesodermal precursor
cells give rise to committed myoblasts that, after proliferation
and migration to appropriate sites in the embryo, exit the cell
cycle, express muscle-specific genes, and fuse into multinucle-
ated myofibers (Pownall et al., 2002). This process is coordi-
nated by a family of myogenic bHLH transcription factors that
includes Myf5, MyoD, myogenin, and MRF4 (Pownall et al.,
2002). These factors function in concert with additional fami-
lies of transcription factors, including MEF2 and NFAT (Puri
and Sartorelli, 2000; Horsley and Pavlath, 2002; McKinsey et
al., 2002). The activity of such transcription factors can be
regulated by signal transduction pathways, although the mech-
anisms involved are not fully understood (Puri and Sartorelli,
2000; Horsley and Pavlath, 2002; McKinsey et al., 2002).
Cell culture systems have proven very useful in analyzing
the processes by which myoblasts differentiate into multinucle-
ated myotubes. Differentiation of myoblast cell lines is induced
by transferring confluent cultures into mitogen-deficient differ-
entiation medium (DM), after which they induce the differenti-
ation factor myogenin, withdraw from the cell cycle, elongate
and align, express muscle-specific proteins, and fuse (Walsh
and Perlman, 1997). Several signaling pathways have been
implicated in promoting myogenic differentiation (Puri and
Sartorelli, 2000; Horsley and Pavlath, 2002; McKinsey et al.,
2002); however, because the most commonly used stimulus for
in vitro differentiation is removal of serum, the extracellular
factors and receptors that initiate these pathways during myo-
genesis are largely unknown.
Differentiation of cells in the skeletal muscle lineage is
also positively regulated by cell–cell contact. We have been
studying this process with particular emphasis on the role of
CDO, an orphan receptor of the Ig/fibronectin type III (FNIII)
repeat family (Kang et al., 1997). CDO is expressed at high
levels in the myogenic compartment during embryogenesis,
and mice lacking CDO via targeted mutagenesis display de-
layed muscle development (Kang et al., 1998; Mulieri et al.,
2000; Cole et al., 2004). CDO also promotes myogenesis
in vitro, signaling through a yet-to-be-identified pathway to
posttranslationally activate MyoD family members through
increased  heterodimerization with their E protein partners
(Kang et al., 1998; Cole et al., 2004). CDO is a component
of a cell surface complex found at sites of cell–cell contact that
also includes the related Ig/FNIII protein BOC and the pro-
myogenic cell adhesion molecules, N- and M-cadherin (Kang
et al., 2002, 2003). We have proposed that this complex me-
diates some of the positive effects of cell–cell contact on
myogenesis.
Netrins comprise a small family of secreted proteins
related to laminins that associate with cell membranes and
ECM (Serafini et al., 1994; Manitt et al., 2001). Netrins func-
tion as evolutionarily conserved axon guidance cues able to
trigger both attractive and repulsive responses mediated via
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two classes of cell surface receptors. The first class belongs,
like CDO, to the Ig/FNIII repeat family and includes DCC and
neogenin; the second class contain Ig and thrombospondin re-
peats and includes the UNC-5H proteins (Huber et al., 2003).
DCC receptors mediate attractive responses to netrins, whereas
complexes of DCC and UNC-5 mediate repulsion (Huber et al.,
2003). Functions for netrins and netrin receptors outside the
nervous system have received much less attention.
Several observations make netrins and their receptors in-
teresting candidates as regulators of myogenesis. First, mRNAs
for netrin-1, netrin-3, and neogenin are expressed in somites
and developing skeletal muscle between E10.5 and E14.5 dur-
ing murine embryogenesis (Gad et al., 1997; Puschel, 1999;
Wang et al., 1999). Second, netrin-1 signals in neurons to acti-
vate several pathways also implicated in promoting myogene-
sis, including the calcineurin, p38 and p42/44 MAPK, and
phosphatidylinositol 3-kinase pathways (Ming et al., 1999;
Forcet et al., 2002; Campbell and Holt, 2003; Graef et al.,
2003). Third, guidance of axons by extracellular cues requires
localized alterations in the actin cytoskeleton of growth cones,
and DCC can signal to modulate the activity of specific Rho
GTPases, known regulators of actin dynamics (Huber et al.,
2003). It seems highly likely that the elongation, alignment,
and fusion steps that occur during myotube formation also re-
quire alterations of the cytoskeleton (Chen et al., 2003). Fi-
nally, netrin-1 and neogenin function in an adhesive, rather
than a guidance, role during mammary gland morphogenesis
(Srinivasan et al., 2003), an activity that could contribute to the
promyogenic effects of cell–cell contact. Interestingly, neoge-
nin morphant zebrafish were recently reported to display de-
fects in somitogenesis (before muscle development) that are
consistent with a potential role for neogenin in convergent ex-
tension (Mawdsley et al., 2004).
We report here that cultured myoblasts express neogenin
and netrin-3. Up- or down-modulation of neogenin levels in-
creases or decreases myotube formation, respectively, and neo-
genin can enhance the activity of myogenic bHLH- and NFAT-
dependent reporter constructs. Treatment of myoblasts with
recombinant netrin promotes myotube formation and NFAT
activation in a neogenin-dependent manner. Finally, neogenin
and CDO form a complex, and CDO modulates netrin signal-
ing. These results suggest that netrin-3 and neogenin promote
myogenic differentiation by an autocrine mechanism, possibly
as components of a higher order complex of several promyo-
genic cell surface proteins.
 
Results
 
Expression of netrins and netrin 
receptors in cultured myoblasts
 
Our interest in Ig/FNIII repeat proteins led us to examine ex-
pression of netrin receptors of this class during myogenic dif-
ferentiation in vitro. Western blot analyses of C2C12 myo-
blasts revealed a uniform level of neogenin in cells cultured in
growth medium (GM) and cells transferred into DM over a pe-
riod of 4 d (Fig. 1 A). This contrasts with expression of CDO,
which was transiently up-regulated during the differentiation
time course (Fig. 1 A; Kang et al., 1998). Duplicate blots
probed with an antibody against DCC revealed only trace lev-
els of this protein (unpublished data). F3, a myoblast line de-
rived by treatment of 10T1/2 fibroblasts with 5-azacytidine,
also expressed neogenin under both GM and DM conditions
(Fig. 1 B). 10T1/2 fibroblasts and 10T1/2 cells converted to
myoblasts by stable expression of MyoD expressed indistin-
guishable levels of neogenin (Fig. 1 C); again, this contrasts
with CDO expression, which was induced by MyoD (Fig. 1 C;
Kang et al., 1998). Finally, expression of oncogenic Ras in
C2C12 cells, which results in reduction of MyoD and CDO and
blocks differentiation (Kang et al., 1998), had no effect on neo-
genin levels (unpublished data). Together, these results indi-
cate that neogenin is expressed in the myogenic lineage, but its
expression is not dependent on myogenic factors.
Specific netrins were examined in a similar fashion. Ne-
trin-3 was expressed in both C2C12 and F3 cells under GM
conditions and levels increased when cells were transferred
into DM (Fig. 1, A and B). This increase was also apparent at
the mRNA level, with C2C12 cells displaying a single 
 
netrin-3
 
transcript of 
 
 
 
7 kb (Fig. 1 D). In contrast, duplicate Western
Figure 1. Expression of neogenin, netrin-3, CDO, and muscle-specific
proteins in C2C12, F3, and 10T1/2 cells. (A) Western blot analysis of
C2C12 cell differentiation. Cultures were brought to  90% confluence
(day 0) and shifted into DM for the indicated period of time and harvested.
Western blots were probed with antibodies against the indicated proteins.
Immunoblotting for myogenin and MHC indicates the progression of cell dif-
ferentiation; immunoblotting with a pan-cadherin antibody serves as a load-
ing control (Kang et al., 2003). (B) Western blot analysis of F3 myoblasts
cultured in GM (G) or DM (D) for 2 d. Blots were probed with antibodies
against the indicated proteins. (C) Western blot analysis of 10T1/2 cell de-
rivatives. 10T1/2 cells stably transfected with a control expression vector
( ) or with a MyoD expression vector ( ) were cultured in DM for 24 h.
Blots were probed with antibodies against the indicated proteins. (D) North-
ern blot analysis of netrin-3 mRNA expression during C2C12 cell differen-
tiation. The ethidium bromide-stained gel is shown as a loading control. 
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and Northern blots probed for expression of netrin-1 protein
and mRNA, respectively, did not reveal a signal, despite the
ability to detect netrin-1 produced transiently (unpublished
data). Netrin-3 produced by C2C12 cells was not observed in
the culture medium supernatant (unpublished data), suggesting
that, like endogenous netrins-1 and -2 in chick floor plate and
netrin-1 in adult rat spinal cord, it is likely to be associated with
cell membranes and/or ECM (Serafini et al., 1994; Manitt et
al., 2001). 10T1/2 and 10T1/2-MyoD cells also expressed ne-
trin-3 (Fig. 1 C). It is concluded that myoblast cell lines and
10T1/2 cells express both netrin-3 and one of its receptors, neo-
genin, raising the possibility that an autocrine signaling path-
way may exist in these cells.
 
Neogenin levels regulate myotube 
formation
 
To assess a role for neogenin in myogenesis, we transfected dif-
ferent “strains” of C2C12 cells and F3 cells with a vector engi-
neered to drive expression of a human neogenin cDNA and a
puromycin resistance gene. Transfected cultures were selected
and analyzed for neogenin expression. Stable overexpression of
neogenin was achieved only in one strain of C2C12 cells. These
cells, previously described by us and designated as C2C12(E)
cells (Kang et al., 1998), are highly differentiation-proficient in
that they: (a) expressed detectable myogenin before a shift into
DM; (b) were less sensitive to inhibition of differentiation by
moderate levels of serum (e.g., 5% FBS); and (c) completed the
differentiation process over a 2-d time period. These cells were
used for all subsequent experiments and are simply referred to
as C2C12 cells. Neogenin vector transfectants (C2C12/neoge-
nin cells) produced two- to threefold more neogenin than con-
trol vector transfectants (C2C12/puro cells; Fig. 2 A). Overpro-
duction of neogenin modestly decreased proliferation of C2C12
cells in GM, relative to vector controls (Fig. S1, available at
http://www.jcb.org/cgi/content/full/jcb.200405039/DC1), and
did not alter their morphology in GM (not depicted). When ob-
served 24 h after shifting the cultures to medium containing 5%
FBS (a time at which the differentiation process was in mid-
progression), C2C12/neogenin cells had formed larger myo-
tubes with more nuclei than did C2C12/puro cells (Fig. 2 B).
C2C12/neogenin cultures displayed an increase in the total
number of nuclei present in myosin heavy chain (MHC)–posi-
tive cells and in the average number of nuclei/myotube (Fig. 2
C). When analyzed for expression of muscle-specific proteins,
including MyoD, myogenin, MHC, and troponin T (TnT),
C2C12/neogenin cells showed accelerated expression of TnT,
but otherwise were similar to C2C12/puro cells (Fig. 2 D).
Overexpression of neogenin therefore resulted in enhanced for-
mation of myotubes without dramatic changes in several bio-
chemical markers of differentiation.
To assess the effect of reducing neogenin levels on myo-
tube formation, an RNAi approach was taken. A sequence from
the mouse neogenin coding region was inserted into the pSi-
lencer vector, and was cotransfected with a GFP expression
vector into C2C12 cells; the pSilencer vector without an insert
was used as a control. Transfected cultures were sorted for the
presence of GFP and assessed for reduction of neogenin levels.
A representative Western blot is shown in Fig. 3 A. GFP-sorted
cells that received the neogenin RNAi vector produced fewer
and smaller myotubes than sorted control transfectants (Fig. S2,
available at http://www.jcb.org/cgi/content/full/jcb.200405039/
DC1). To more precisely quantify this effect, C2C12 cells were
cotransfected with the neogenin RNAi vector or the vector
lacking an insert, plus a plasmid directing expression of 
 
nlacZ
 
(encoding nuclear-localized 
 
 
 
-galactosidase; 
 
 
 
-gal). 2 d later,
the cultures were transferred to 5% FBS for 24 h, and then fixed
and double stained for MHC and 
 
 
 
-gal activity. When control
vector-transfectants fused with nontransfected cells, many (of-
ten most) of the nuclei in the myotube became positive for
 
 
 
-gal activity, presumably because the cytoplasmically translated
Figure 2. Overexpression of neogenin promotes myotube
formation by C2C12 cells. (A) C2C12 cells were stably
transfected with a control expression vector lacking a
cDNA ( ) or with an expression vector harboring a neo-
genin cDNA ( ). Western blots of the indicated cells
were probed with neogenin or, as a control, pan-cadherin
antibodies. The exposure of this film was for a shorter
duration than the neogenin blot shown in Fig.1, so as to
more clearly highlight the quantitative difference between
the transfectants. (B) Photomicrographs of C2C12/puro
and C2C12/neogenin cells were cultured in 5% FBS
for 24 h, and fixed and stained with an antibody to
MHC. Bar, 0.2 mm. (C) Quantification of myotube forma-
tion. Values represent means of triplicate determinations  
1 SD. (D) Western blot analysis of muscle-specific pro-
teins by C2C12 cell transfectants over a 2-d time course
of differentiation. 
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protein diffused within the myotube (Fig. 3 B). When the num-
ber of nuclei in 
 
 
 
-gal
 
 
 
 cells was scored, 
 
 
 
56% had more than
five nuclei, 
 
 
 
21% had two to four nuclei and 
 
 
 
23% had a sin-
gle nucleus (Fig. 3 C). In contrast, the distribution of 
 
 
 
-gal
 
 
 
cells that received the neogenin RNAi vector was strongly
skewed toward single nucleus-containing cells, with only about
 
 
 
5% displaying more than five nuclei (Fig. 3 C). Cells that re-
ceived an RNAi vector containing a neogenin sequence that
was ineffective at reducing neogenin protein levels behaved
equivalently to those that received the vector lacking an insert
(unpublished data).
As a further test of specificity, we sought to rescue the
cell fusion defect produced by neogenin RNAi via ectopic ex-
pression of the human neogenin cDNA. The sequence of the
RNAi used to target endogenous mouse neogenin is not fully
conserved in the human cDNA, and therefore the human neo-
genin expression vector should be impervious to RNAi-medi-
ated “knockdown”. Three conditions were studied: (1) C2C12
cells cotransfected with pSilencer lacking RNAi sequences and
the control vector for human neogenin expression (pSil/pBP);
(2) cells cotransfected with pSilencer containing neogenin
RNAi sequences and the control vector for human neogenin
expression (RNAi/pBP); and (3) cells cotransfected with pSi-
lencer containing RNAi sequences and the human neogenin ex-
pression vector (RNAi/hNeogenin). For unknown reasons, the
pSil/pBP transfectants reproducibly produced fewer myotubes
with more than five nuclei than cells that received only the con-
trol pSilencer vector (
 
 
 
30% vs. 
 
 
 
56%, respectively; compare
Fig. 3 D with Fig. 3, C and E). Importantly, however, RNAi/
pBP transfectants were strongly blocked from forming myo-
tubes, whereas the RNAi/hNeogenin transfectants closely re-
sembled the control pSil/pBP cultures (Fig. 3, D and E). There-
fore, forced expression of neogenin rescued the effects of
RNAi to neogenin, further indicating that the effects of the
RNAi were specific. It is concluded that reduction of neogenin
levels reduced myoblasts’ ability to participate in the formation
of myotubes. Together, with the overexpression data in Fig. 2,
these results strongly suggest that neogenin levels are rate lim-
iting for this aspect of C2C12 myogenesis.
 
Recombinant netrin promotes myotube 
formation
 
To assess the effects of netrin-3 on myoblast cell lines, we ini-
tially attempted to synthesize recombinant mouse protein in
COS and 293T cells but, similar to the findings of Puschel
(1999), were unable to produce sufficient quantities of se-
creted, soluble material. Mouse netrin-3 is orthologous to hu-
man netrin-2L and, although not orthologous to chicken netrin-2,
is grouped with both these proteins by dendrogram analyses
in a sub-category designated “netrin-2–like”, distinguishable
from a “netrin-1–like” group (Puschel, 1999). Therefore, we
chose to use recombinant chicken netrin-2 for this work as it is
Figure 3. RNAi-mediated reduction of neogenin levels
blocks myotube formation. (A) Western blot analysis of
RNAi-mediated “knockdown” of neogenin. C2C12 cells
were transiently transfected with a GFP expression vector
and either pSilencer ( ) or pSilencer containing neogenin
RNAi sequences ( ). GFP-positive cells were sorted and
cell lysates probed with antibodies to neogenin or, as a
control, a pan-cadherin antibody. (B) C2C12 cells were
transiently transfected with pSilencer (control) or pSilencer
containing RNAi sequences targeted against neogenin,
plus an expression vector for nlacZ (nuclear-targeted  -gal).
Cultures were fixed and double stained for MHC and
 -gal activity. Bars: (top) 0.2 mm; (bottom): a higher
magnification micrograph, 0.1 mm. (C) Quantification of
myotube formation. Values represent means of triplicate
determinations   1 SD. (D) C2C12 cells were transiently
transfected with pSilencer and pBabePuro (pSil/pBP);
pSilencer containing neogenin RNAi sequences and
pBabePuro (RNAi/pBP); or pSilencer containing neogenin
RNAi sequences and pBabePuro harboring a human neo-
genin cDNA (RNAi/hNeogenin), in each case plus an
expression vector for nlacZ. Cultures were fixed and double
stained for MHC and  -gal activity. Bar, 0.2 mm. (E) Quan-
tification of myotube formation. Values represent means of
triplicate determinations   1 SD. The transfection efficien-
cies for these experiments were  10%, a value chosen to
minimize fusion of independent  -gal
  transfectants. 
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commercially available. C2C12 cells were cultured in GM,
then transferred into 5% FBS plus or minus chicken netrin-2,
and observed 24 h later. C2C12 cell proliferation was not
altered by netrin-2 treatment (Fig. S3, available at http://
www.jcb.org/cgi/content/full/jcb.200405039/DC1). However,
although the control cultures displayed small MHC
 
 
 
 myotubes
under these conditions, the netrin-2–treated cultures showed
distinctly larger myotubes with increases in the total number of
nuclei in MHC
 
 
 
 cells and in the average number of nuclei/myo-
tube (Fig. 4, A and B). When analyzed for expression of mus-
cle-specific proteins, the cells that received netrin-2 produced
significantly more TnT than control cells, but the levels of
MyoD, myogenin, MHC, and CDO were unchanged (Fig. 4 C).
Thus, similar to overexpression of neogenin, treatment of
C2C12 cells with a neogenin ligand resulted in enhanced myo-
tube formation and alterations in expression of TnT, but not
several other muscle markers.
To assess whether netrin-2 exerted its effects on myo-
tube formation in a manner dependent on neogenin, a C2C12
cell derivative that stably expressed the neogenin RNAi vec-
Figure 4. Netrin-2 promotes myotube formation. (A) Photomicrographs of C2C12 cells were treated with 5% FBS plus or minus recombinant chicken
netrin-2 for 24 h, and fixed and stained with an antibody to MHC. Bars: (top) 0.5 mm; (bottom) 0.2 mm. (B) Quantification of myotube formation. Values
represent means of triplicate determinations   1 SD. (C) Western blot analysis of muscle-specific proteins by C2C12 cells treated with 5% FBS plus or
minus recombinant chicken netrin-2 for 24 h. Cell lysates were probed with the indicated antibodies.
Figure 5. Netrin-2 requires neogenin to stim-
ulate myotube formation. (A) Western blot
analysis of neogenin production by stable
control ( ) and neogenin RNAi ( ) vector
transfectants. (B) Photomicrographs of the cells
from A were treated with 5% FBS plus or minus
netrin-2 for 24 h, and fixed and stained with an
antibody to MHC. Bar, 0.2 mm. (C) Quantifi-
cation of myotube formation. Values represent
means of triplicate determinations   1 SD. 
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tor was generated; these cells expressed considerably less
neogenin than control transfectants and produced fewer and
smaller myotubes than control transfectants when shifted to
DME/5% FBS for 24 h (Fig. 5, A–C). When the control cells
were treated with netrin-2 under these conditions they be-
haved similarly to parental C2C12 cells, forming larger myo-
tubes with more nuclei. In contrast, the neogenin RNAi-
expressing cells were not affected by netrin-2 (Fig. 5, B and
C). Therefore, it is concluded that the ability of netrin-2 to
promote myotube formation by C2C12 cells depends on the
netrin receptor, neogenin.
 
Neogenin activates myogenic bHLH 
factor– and NFAT-dependent reporter 
constructs
 
CDO signals to enhance myogenic bHLH factor–dependent
transcription (Cole et al., 2004), and netrin-1 signals through
DCC to stimulate NFAT-mediated transcription (Graef et al.,
2003). Therefore, we assessed whether neogenin could stimu-
late reporter constructs specific for myogenic bHLH factors and
NFAT. In transient assays of C2C12 cells, cotransfection of the
neogenin expression vector enhanced activity of a reporter con-
struct driven by four reiterated myogenic E-boxes (4Rtk-luc),
approximately threefold above that seen with a control vector
lacking a cDNA insert (Fig. 6 A). Cotransfection of 10T1/2 fi-
broblasts with expression vectors for MyoD and its hetero-
dimeric partner E12 led to activation of 4Rtk-luc, and this activ-
ity was also enhanced approximately threefold by coexpression
of neogenin (Fig. 6 B). However, neogenin could not activate
the reporter in the absence of MyoD (unpublished data).
Cotransfection of the neogenin expression vector into ei-
ther C2C12 or 10T1/2 cells enhanced NFAT-luciferase re-
porter activity approximately twofold; in contrast, a CDO ex-
pression vector had no effect on NFAT-dependent transcription
(Fig. 6, C and D). Of the various NFATc isoforms implicated
in myogenesis, only NFATc3 is activated in differentiating
C2C12 myoblasts (Delling et al., 2000). To assess whether ne-
trin-neogenin signaling could activate NFATc3, C2C12 and
10T1/2 cells were treated with recombinant chicken netrin-2
for 6 or 30 h. Immunoblots probed with an antibody specific to
NFATc3 revealed increased levels of NFATc3 after 6 h of ne-
trin-2 treatment, including a more quickly migrating form that
presumably represents dephosphorylated, activated NFATc3
(Fig. 6 E). This response returned to baseline, or lower, within
30 h. Consistent with this relatively short duration of action,
addition of netrin-2 to control or neogenin-transfected cultures
enhanced NFAT-luciferase reporter activity by only 
 
 
 
40% in
each case (unpublished data).
Figure 6. Neogenin enhances myogenic bHLH factor– and NFAT-dependent transcription. (A) C2C12 cells were transiently transfected with 4Rtk-luc and
either a control or neogenin expression vector and analyzed for luciferase reporter activity. (B) 10T1/2 cells were transiently transfected with 4Rtk-luc,
expression vectors for MyoD and E12, and either a control or neogenin expression vector and analyzed for luciferase reporter activity. (C) C2C12 cells
were transiently transfected with NFAT-luc and a control, neogenin or CDO expression vector and analyzed for luciferase reporter activity. (D) 10T1/2
cells were transiently transfected with NFAT-luc and either a control or neogenin expression vector and analyzed for luciferase reporter activity. (A–D) Values
are means   1 SEM from three experiments, each performed in triplicate. (E) Western blot analysis of NFATc3 in C2C12 and 10T1/2 cells treated with
5% FBS plus or minus recombinant chicken netrin-2 for 6 or 30 h. Cell lysates were probed with the indicated antibodies. The top and bottom arrows
indicate the presumptive phosphorylated and dephosphorylated forms of NFATc3, respectively. (F and G) Netrin-2 requires neogenin to stimulate NFATc3
levels. (F) Western blot analysis of NFATc3 in C2C12 cells transiently transfected with control ( ) or neogenin RNAi ( ) vectors that were sorted and
treated with 5% FBS plus or minus netrin-2. (G) Similar to F except that the cells were the stable neogenin RNAi transfectants shown in Fig. 5. 
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To assess whether the effects of netrin-2 on NFATc3
were dependent on neogenin, C2C12 cells were transiently
transfected with neogenin RNAi or control vectors plus a GFP
expression vector, sorted, and treated with medium containing
5% FBS, plus or minus netrin-2. Netrin-2 treatment of control
transfectants resulted in increased levels of NFATc3, similar to
parental C2C12 cells; in contrast, neogenin RNAi transfectants
failed to respond to netrin-2 (Fig. 6 F). The C2C12 derivative
that stably expressed neogenin RNAi (Fig. 5) displayed a simi-
lar lack of response (Fig. 6 G). Thus, as seen with enhancement
of myotube formation, netrin-2 required neogenin to exert its
effects on NFATc3 levels.
 
Neogenin forms a complex with CDO
 
Ig/FNIII proteins can bind in a cis fashion to additional mem-
bers of this family to form complexes that regulate their func-
tion. For example, Robo receptors bind to DCC to silence ne-
trin-1–mediated attraction (Stein and Tessier-Lavigne, 2001),
and BOC binds CDO to stimulate myogenesis (Kang et al.,
2002). To test whether neogenin might also interact with CDO,
lysates from C2C12 and F3 cells were immunoprecipitated
with antibodies to CDO or neogenin and blotted with the recip-
rocal antibody. Neogenin was present in CDO immunoprecipi-
tates, and CDO in neogenin immunoprecipitates, from both cell
lines, suggesting that these two proteins do indeed form a com-
plex (Fig. 7, A and B). More neogenin co-immunoprecipitated
with CDO under DM than GM conditions, although this en-
hanced association in DM was not evident in the reciprocal co-
immunoprecipitation (Fig. 7, A and B). Co-immunoprecipita-
tion of neogenin and CDO was not diminished when C2C12
cells were collected as a single-cell suspension in the presence
of EDTA (which blocks cadherin-mediated adhesion), suggest-
ing that the interaction occurs in a cis fashion (Fig. 7 C). CDO
associates with N- and M-cadherins in myoblasts (Kang et al.,
2003), and cadherins also co-immunoprecipitated with neoge-
nin (Fig. 7 B), suggesting these proteins may interact together
in a higher order structure. Furthermore, consistent with netrin-3
functioning as a neogenin ligand in C2C12 cells, it too was ob-
served in neogenin immunoprecipitates (Fig. 7 B).
To investigate complex formation between CDO and
neogenin in more detail, transient transfections in 293T cells
were performed. Neogenin was brought down by CDO anti-
bodies when CDO was coexpressed, but not when CDO was
omitted; analogously, CDO was brought down by neogenin
antibodies in a neogenin-dependent fashion (Fig. 7, D and E).
As seen with C2C12 cells, collection of transiently trans-
Figure 7. Neogenin and CDO form complexes. Lysates from the indicated cell lines were immunoprecipitated (IP) and Western blotted (WB) with the indicated
antibodies. Immunoblotting of straight lysates with antibodies to nonimmunoprecipitated proteins are shown as a control. (A and B) C2C12 cells were
cultured in GM (G) or DM (D). Immunoblotting of straight lysates to MHC in A indicates the degree of differentiation of the cells. (C) C2C12 cells were
cultured on plastic dishes ( ) or as a single cell suspension in the presence of EDTA ( ). (D and E) 293T cells were transiently transfected with expression
vectors for neogenin and/or CDO as indicated. (F) 293T cells were transiently transfected with expression vectors for neogenin and CDO and cultured on
plastic dishes ( ) or as a single cell suspension in the presence of EDTA ( ). (G) 293T cells were transiently transfected with expression vectors for neogenin
and either full-length CDO (CDO) or CDO deletion mutants as indicated. 
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fected 293T cells as a single-cell suspension in EDTA did not
diminish the association between neogenin and CDO (Fig. 7
F). Additionally, when 293T transfectants that expressed
only CDO were cocultured with transfectants that expressed
only neogenin, immunoprecipitation of either protein failed
to coprecipitate the other, an interaction expected to be ob-
served if the binding occurred in a trans manner (unpublished
data). Together, the transient expression data: (a) establish
the specificity of the antibodies; (b) confirm the cis nature of
the CDO-neogenin association; and (c) indicate that addi-
tional, cell type–specific factors are not likely to be required
for this interaction.
CDO contains an ectodomain comprised of five Ig and
three FNIII repeats, a single pass transmembrane region, and a
270–amino acid cytoplasmic tail (Kang et al., 1997). To iden-
tify regions of CDO involved in complex formation with neo-
genin, a series of CDO deletion mutants that lack each indi-
vidual Ig and FNIII repeat were tested for their ability to
co-immunoprecipitate neogenin. 293T cells were transiently
transfected with expression vectors for neogenin and either
wild-type CDO or individual CDO mutants (designated by the
symbol “
 
 
 
” followed by the deleted domain). Cell lysates were
precipitated with antibodies to the CDO intracellular region,
and the immunoprecipitates blotted and probed with antibodies
to neogenin or CDO (Fig. 7 G). The CDO mutants 
 
 
 
Ig1 and
 
 
 
FN2 were deficient (though not completely defective) in their
ability to associate with neogenin, relative to full-length CDO.
In contrast, 
 
 
 
Ig2, 
 
 
 
Ig4, 
 
 
 
Ig5, and 
 
 
 
FN1 displayed no signifi-
cant reduction in this property. 
 
 
 
FN3 gave somewhat variable
results over multiple experiments, suggesting it may be in-
volved in neogenin binding but is not as important as Ig1 or
FN2. Deletion of Ig repeat 3 apparently resulted in destabiliza-
tion of CDO, as only very weak expression of this protein was
observed. A construct in which the CDO signal sequence was
linked directly to its transmembrane and cytoplasmic regions
(designated CDO(TMintra); Kang et al., 2002) was brought
down in neogenin immunoprecipitates, albeit inefficiently,
suggesting that the intracellular regions of CDO and neogenin
may also associate (unpublished data). Together, the results in
Fig. 7 are consistent with the conclusion that neogenin and
CDO form complexes in cis and that this interaction is depen-
dent on the presence of specific repeats in the CDO ectodomain.
Despite its sequence similarity to, and ability to interact with,
neogenin, CDO seems not to be an independent netrin receptor,
in that it was unable to bind a netrin-1-Fc fusion protein under
conditions where neogenin did. Furthermore, BOC was also
unable to bind netrin-1-Fc, and coexpression of CDO and/or
BOC did not appear to alter netrin-1-Fc binding to neogenin
(unpublished data).
To gain insight into whether neogenin’s ability to bind to
CDO is important for netrin-neogenin signaling, primary myo-
blasts derived from wild-type mice and mice homozygous for a
targeted mutation of 
 
Cdo
 
 were analyzed for their response to re-
combinant chicken netrin-2. 
 
Cdo
 
 
 
/
 
 
 
 and 
 
Cdo
 
 
 
/
 
 
 
 myoblasts ex-
press similar levels of MyoD, but during differentiation 
 
Cdo
 
 
 
/
 
 
 
cells produce lower levels of myogenin and form myotubes very
inefficiently (Cole et al., 2004). Like myoblast cell lines, pri-
mary myoblasts expressed netrin-3 and neogenin, regardless of
their 
 
Cdo
 
 genotype (Fig. 8 A). Before treatment with netrin-2,
 
Cdo
 
 
 
/
 
 
 
 and 
 
Cdo
 
 
 
/
 
 
 
 myoblasts were similar in that each ex-
pressed somewhat higher levels of the more slowly migrating
form of NFATc3 than the more quickly migrating, presumably
activated, form (Fig. 8 B). After 3 h of exposure to netrin-2, the
 
Cdo
 
 
 
/
 
 
 
 cells showed a pronounced shift to the more quickly mi-
grating form, consistent with activation of NFAT signaling; in
contrast, the 
 
Cdo
 
 
 
/
 
 
 
 myoblasts showed no response and the ra-
tio of the two forms of NFATc3 resembled that seen in un-
treated cells (Fig. 8 B). Therefore, loss of CDO resulted in loss
of responsiveness to netrin-2 despite the presence of normal lev-
els of its receptor, suggesting that neogenin’s interaction with
CDO is important for signaling by this pathway.
 
Discussion
 
Skeletal myogenesis is widely studied as a model system for
the study of lineage specification and cell differentiation. One
reason for this is the tractability of myoblast cell lines, which
are easily induced to differentiate into myotubes by removal
of serum from the culture medium. Consistent with serum
deprivation promoting myogenic differentiation is the obser-
vation that many commonly studied growth factors are antag-
onistic to this process (Olson, 1992). However, the positive
regulation of myogenesis by signal transduction pathways
(Puri and Sartorelli, 2000; Horsley and Pavlath, 2002; Mc-
Kinsey et al., 2002) strongly suggests that myoblast differen-
tiation is promoted by extracellular signaling ligands working
via cell surface receptors. Although a few such factors have
been identified, including IGF1, prostaglandin F
 
2
 
 
 
, and inter-
leukin-4 (James et al., 1996; Horsley and Pavlath, 2003;
Horsley et al., 2003), the small number currently known is
striking by comparison with the advanced state of knowledge
on transcriptional regulation of differentiation. Here, it is
demonstrated for the first time that netrins and the netrin re-
ceptor, neogenin, promote myotube formation in vitro. Fur-
thermore, this is one of the only reports of a function for ne-
trins outside the nervous system, broadening their potential
roles in morphogenesis.
Figure 8. CDO is required for netrin-2 to produce the activated form of
NFATc3. (A) Western blot analysis of neogenin, CDO, netrin-3, and MyoD
in primary myoblasts isolated from wild-type ( / ) and Cdo
 /  ( / )
mice. (B) Western blot analysis of NFATc3 in primary myoblasts of the
indicated Cdo genotype treated with or without netrin-2 for 3 h. The top
and bottom arrows indicate the presumptive phosphorylated and dephos-
phorylated forms of NFATc3, respectively. 
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Netrins and neogenin promote myotube 
formation
 
Several lines of evidence indicate that netrin-neogenin signal-
ing promotes specific aspects of myoblast differentiation: (a)
myoblast cell lines and primary myoblasts express both netrin-3
and neogenin; (b) overexpression of neogenin enhanced myo-
tube formation by C2C12 cells, whereas RNAi-mediated
“knockdown” of neogenin inhibited it; (c) exogenous chicken
netrin-2 enhanced myotube formation in a neogenin-dependent
fashion; (d) neogenin increased the activity of myogenic bHLH
factor– and NFAT-dependent reporters; and (e) netrin-2 treat-
ment increased the levels of the activated form of NFATc3,
again in a neogenin-dependent fashion. Taking these results to-
gether, we propose that netrin-3 and neogenin function in an
autocrine loop to stimulate myotube formation.
Although exogenously supplied chicken netrin-2 and
both endogenous and exogenously expressed neogenin clearly
stimulated myotube formation, certain aspects of this putative
autocrine loop remain to be established. First, the level of neo-
genin produced by C2C12 cells did not change during differen-
tiation, and, whereas netrin-3 did increase in DM, it was also
produced by cells in GM. Thus, something in addition to the
amounts of these proteins may keep their signaling activities in
check when the cells are in GM. Because netrins are not freely
soluble, but rather are associated with cell membranes and
ECM (Serafini et al., 1994; Manitt et al., 2001), one possibility
is that netrin-3 on the surface of one cell and neogenin on the
surface of another may only encounter each other as a conse-
quence of close cell–cell proximity. Consistent with this possi-
bility, netrin-3 produced by C2C12 cells was not detected in
cell culture supernatants (unpublished data). Cell–cell contact
is a promyogenic condition, and netrin-neogenin interactions
may contribute to this phenomenon (see next sub-section of
Discussion). Second, it should be noted that our evidence for
netrin function in myoblasts relies on the use of exogenously
provided chicken netrin-2, and it has not yet been possible to
generate direct evidence that endogenous netrin-3 works iden-
tically. Unfortunately, none of several different netrin-3 RNAi
sequences resulted in reduction of netrin-3 protein levels (un-
published data), and neutralizing antibodies to netrin-3 are not
available. However, netrin-2 required neogenin for its effects
on C2C12 cells; netrin-3 fusion proteins bind to neogenin
(Puschel, 1999; Wang et al., 1999); and endogenous netrin-3
co-immunoprecipitated with endogenous neogenin in C2C12
cell extracts. Therefore, it seems likely that netrin-3 is a func-
tional neogenin ligand in myoblasts, particularly as these cells
did not express detectable netrin-1.
Another interesting aspect of netrin-2 and neogenin activ-
ity in myoblasts was that these factors stimulated myotube for-
mation without significantly altering the level of several mus-
cle-specific gene products, including MyoD, myogenin, and
MHC. In contrast, the levels of another muscle-specific pro-
tein, TnT, were increased by treatment of C2C12 cells with ne-
trin-2, and induction of TnT was accelerated in C2C12/neoge-
nin cells. It is possible that TnT represents a specific target of
netrin/neogenin signaling. Consistent with this possibility are
the observations that neogenin enhanced myogenic bHLH fac-
tor– and NFAT-dependent transcription in reporter assays, and
netrin-2 treatment led to production of the activated form of
NFATc3. Alternatively, it is possible that TnT expression is
maximized within the cellular environment of the myotube,
and that the elevated levels of this protein seen in netrin-2–
treated cells occur secondarily to enhancement of myotube for-
mation. It may be that, while transcriptional regulation plays a
role in netrin-neogenin-mediated myotube formation, the most
important pathways involved in this process are similar to
those used by these families of molecules to alter the cytoskele-
ton in migrating and turning growth cones (Huber et al., 2003).
Dynamic changes in cytoskeletal architecture are highly likely
to be necessary for the elongation, alignment, adhesion and fu-
sion steps of myotube formation; although these processes oc-
cur simultaneously with induction of muscle-specific gene ex-
pression, they may not be strictly dependent on transcriptional
regulation. The established ability of netrins and their receptors
to signal locally at the tips of axonal growth cones makes them
appealing candidates as regulators of the morphological changes
that occur during formation of myotubes, independent of their
ability to stimulate transcription.
 
Cell surface receptor complexes and 
regulation of myogenic differentiation
It has long been appreciated that cell–cell contact and/or high
cell density positively regulates myogenesis. This is apparent
in disparate phenomena, such as the community effect in de-
termination of the muscle lineage and the need for aggrega-
tion for differentiation of certain myogenic cell lines (Gurdon
Figure 9. A working model for a promyogenic cell surface complex. A
complex of cell surface receptors and adhesion molecules found at sites of
myoblast cell–cell contact includes CDO and BOC, which may function as
a receptor for a yet-to-be identified ligand. CDO and BOC interact in cis
with N- and M-cadherins, which bind  - and  -catenin. CDO and BOC
also interact with neogenin, a receptor for netrin-3. Multiple signals appear
to emanate from this complex, resulting in activation of myogenic bHLH
and NFAT transcription factors and alteration of the actin cytoskeleton in
preparation for fusion. Note that although cis dimers of cadherins are
shown, no stoichiometry of complex formation between CDO, BOC and
neogenin, or between these proteins and cadherins, is implied by the
figure. Note also that the experiments that support this working model do
not distinguish between the existence of a single complex containing each
protein shown or multiple complexes in which some components may be
mutually exclusive. See text for further details.JCB • VOLUME 167 • NUMBER 3 • 2004 502
et al., 1993; Skerjanc et al., 1994; Redfield et al., 1997). We
have been studying a cell surface complex found at sites of
cell–cell contact which is depicted as a model in Fig. 9 and
that includes: (a) the related Ig/FNIII proteins CDO and
BOC; and (b) the promyogenic cell adhesion molecules,
N- and M-cadherin, and the cadherin-associated proteins  - and
 -catenin (Kang et al., 2002, 2003; and unpublished data for
 -catenin). This complex is well-situated to coordinate mul-
tiple aspects of myogenesis. CDO signals to posttranslation-
ally activate MyoD family members through increased hetero-
dimerization with E proteins, most likely via CDO-directed
phosphorylation of E12/E47 (Cole et al., 2004). Cadherins
mediate cell–cell adhesion via tethering to the actin cytoskel-
eton and signal to increase the activity of the promyogenic
small GTPase, RhoA (Takano et al., 1998; Charrasse et al.,
2002). This work demonstrated that neogenin also binds to
CDO in a cis fashion. Furthermore, netrin-3 and cadherins co-
immunoprecipitated with neogenin. By analogy with netrin-1
and DCC (Stein et al., 2001), it seems likely that netrin-3
binds directly to neogenin; however, the neogenin-cadherin
interaction might occur directly or indirectly via neogenin
binding to CDO and/or BOC, which may provide direct asso-
ciation with cadherins. The formation of such a receptor com-
plex or complexes in myoblasts resembles an emerging pic-
ture of axon guidance receptor complexes in growth cones.
DCC/UNC-40 family proteins (which include neogenin) in-
teract in cis with netrin receptors of the UNC5 family; with
Robo proteins, which are Ig/FNIII domain-containing recep-
tors for the Slit family of ligands; and with an Ig/FNIII do-
main-containing receptor tyrosine phosphatase (Hong et al.,
1999; Stein and Tessier-Lavigne, 2001; Chang et al., 2004).
Robo receptors, in turn, can form cis complexes with N-cad-
herin (Rhee et al., 2002).
The dynamics of neither the axon guidance receptor com-
plexes nor the complexes in myoblasts that we have described
are well understood. Purification and analysis of native com-
plexes will be required to address how many transmembrane
components can be part of a single complex and whether some
interactions are mutually exclusive. However, a key aspect of
the myoblast model is that the components of the complex or
complexes display interdependence in some of their promyo-
genic activities. Examples include: (a) CDO must be capable of
binding to cadherins to stimulate differentiation of C2C12
cells; (b) BOC is dependent on CDO to promote differentiation
of C2C12 cells; and (c) netrin-3 (assuming it acts similarly to
netrin-2) requires not only its receptor, neogenin, but also
CDO, to stimulate myotube formation. Assembly of a multi-
protein complex localized at sites of cell–cell contact and con-
taining multiple signaling and adhesive components is an
appealing notion, as such complexes could permit diverse sig-
naling events that regulate both morphological and transcrip-
tional responses to be coordinated during differentiation from a
site in the cell that must undergo dramatic changes as myo-
blasts elongate, align, and ultimately fuse. Complete identifica-
tion of the components and dynamics of such complexes
should provide important insights into myogenesis in particular
and cell differentiation in general.
Materials and methods
Cell culture
C2C12, F3, and 10T1/2 cells were cultured as described previously
(Kang et al., 1998, 2002). Differentiation of C2C12 and F3 cells was in-
duced by switching cultures from DME/15% FBS to either DME/2% horse
serum (DM) or DME/5% FBS as indicated. All quantified myotube forma-
tion assays were performed at least four times with similar results. COS
and 293T cells were cultured in DME/10% FBS. Primary myoblasts were
obtained from the hind limbs of wild-type and Cdo
 /  mice (Cole and
Krauss, 2003) at postpartum day 21 by the methods of Rando and Blau
(1994) and Sabourin et al. (1999). In brief, muscle tissue was collected,
connective tissue and fat removed, and muscles dissociated mechanically
and enzymatically. Cells were plated on tissue-culture plastic in Ham’s
F10 medium with 20% FBS, 10 ng/ml hepatocyte growth factor, 5 mg/ml
heparin, and 2.5 ng/ml bFGF. Floating cells were collected 24 h later, in-
oculated on collagen-coated plates and cultured in the same medium with-
out hepatocyte growth factor. Several rounds of selective adhesion were
performed until a pure population of myoblasts (as assessed by immunocy-
tochemistry for MyoD) was obtained. Cultures were treated with recombi-
nant chicken netrin-2 (R & D Systems; 25 ng/ml) in fresh DME/5%FBS.
Stable expression of, and RNAi against, neogenin
A cDNA comprising a complete human neogenin ORF was provided by E.
Fearon (University of Michigan, Ann Arbor, MI) and inserted into the ex-
pression vector, pBabePuro. C2C12 cells were transfected with this vector
or a vector lacking a cDNA insert with the FuGene6 reagent (Roche), and
puromycin-resistant colonies selected and pooled for analysis. For RNAi
studies, three sequences against mouse neogenin were tested initially. Oli-
gonucleotides corresponding to the neogenin sequences were cloned into
the pSilencer 2.0-U6 vector (Ambion), and 9.0  g of the individual
vectors or parental vector were transfected with 1.0  g of an EGFP ex-
pression vector (CLONTECH Laboratories, Inc.) into C2C12 cells with
FuGene6. GFP-positive cells were isolated 24 h later, with a FACDiVa
flow cytometer (Becton Dickinson) and identical numbers of cells replated.
The cultures were harvested 48 h later and analyzed for neogenin ex-
pression by Western blotting. The most effective sequence was chosen
for further use and corresponds to nucleotides 3180–3198 of the Gen-
Bank sequence of murine neogenin (GenBank/EMBL/DDBJ accession
no. NM_008684: ACCTAGAACCATCATAGTG). To test the effects of
RNAi to neogenin on myotube formation, 10-cm plates of C2C12 cells
were cotransfected with 9.5  g of control or neogenin RNAi vector with
0.5  g of pQ-lacZ, a vector driving expression of nuclear-localized  -gal
(provided by D. Sassoon, Mount Sinai School of Medicine). 48 h after
transfection, the cultures were transferred to DME plus 5% FBS to stimulate
differentiation; 24 h later the cells were fixed with 4% PFA, permeabilized
with 0.01% NP-40 and stained for  -gal activity with X-gal. The cultures
were subsequently immunostained for MHC expression as described pre-
viously (Kang et al., 1998). For rescue experiments, the transfections in-
cluded 4.5  g control or neogenin RNAi vector, 4.5  g pBabePuro or
pBabePuro-hNeogenin vector, and 0.5  g pQ-lacZ; the remainder of the
protocol was identical.
Protein and RNA analysis
Western blot analyses were performed as described in Kang et al.
(1998). Antibodies used were antineogenin (Santa Cruz Biotechnology,
Inc.); antinetrin-3 (provided by H. Cooper, Walter and Eliza Hall Institute,
Victoria, Australia; Seaman and Cooper, 2001); anti-DCC (Santa Cruz
Biotechnology, Inc.); anti-NFATc3 (Santa Cruz Biotechnology, Inc.); anti-
CDO (Zymed Laboratories); antipan cadherin (Sigma-Aldrich); anti-MHC
(MF20; Developmental Studies Hybridoma Bank); anti-MyoD (Santa Cruz
Biotechnology, Inc.); antimyogenin (F5D; Santa Cruz Biotechnology, Inc.);
and anti-TnT (Sigma-Aldrich).
To study neogenin–CDO complex formation, co-immunoprecipita-
tion techniques were performed as described previously (Kang et al.,
2002). CDO deletion mutants lacking each individual ectodomain repeat
were constructed by a combination of PCR and conventional cloning tech-
niques and verified by sequence analysis. The CDO(TMintra) mutant was
previously described (Kang et al., 2002). Details on the construction of
these mutants are available on request.
Total cellular RNA was isolated with the TRIzol reagent (Life Tech-
nologies). Northern blot analyses with 
32P-labeled probes were performed
as described previously (Kang et al., 1997). Mouse netrin-1 and netrin-3
cDNA probes were derived from mouse EST clones obtained from Open
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Luciferase assays
C2C12 and 10T1/2 cells cultured in 6-well plates were cotransfected with
4Rtk-luc or NFAT-luc reporters (500 ng; provided by A. Lassar, Harvard Uni-
versity, Cambridge, MA, and G. Crabtree, Stanford University, Stanford,
CA, respectively), pBabePuro or pBabePuro-neogenin (500 ng), and pCMV-
lacZ as an internal control (50 ng) using FuGene6. In the case of 4Rtk-luc
assays in 10T1/2 cells, 5 ng each of MyoD and E12 expression vectors
were also included. 48 h after transfection, cells were harvested and lu-
ciferase activity assessed with the Promega luciferase assay system kit.
Microscopy
Cultures were processed for MHC expression and/or  -gal activity as de-
scribed above and examined on a phase contrast microscope (model
Eclipse TS100; Nikon) with Plan Fluor 10 /0.3 and 20 /0.45 objectives
(Nikon), at RT. Images were captured with a Spot RT Color camera (model
2.2.1) using Spot software (version 3.5.9) and Adobe Photoshop 7.0.
Online supplemental material
Fig. S1 shows growth curves of C2C12/puro and C2C12/neogenin cells.
Fig. S2 shows that expression of neogenin RNAi reduces myotube forma-
tion in GFP-sorted cells. Fig. S3 shows growth curves of C2C12 cells
treated with 5% FBS plus or minus netrin-2. Online supplemental material is
available at http://www.jcb.org/cgi/content/full/jcb.200405039/DC1.
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